Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05282901 |
Title | Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME) (PLUME) |
Acronym | PLUME |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Institut Curie |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | FRA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Institut Curie | RECRUITING | Paris | 75005 | France | Details |